Tramsen, L.; Bochennek, K.; Sparber-Sauer, M.; Salzmann-Manrique, E.; Scheer, M.; Dantonello, T.; Borkhardt, A.; Dirksen, U.; Thorwarth, A.; Greiner, J.;
et al. Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials. Cancers 2023, 15, 2050.
https://doi.org/10.3390/cancers15072050
AMA Style
Tramsen L, Bochennek K, Sparber-Sauer M, Salzmann-Manrique E, Scheer M, Dantonello T, Borkhardt A, Dirksen U, Thorwarth A, Greiner J,
et al. Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials. Cancers. 2023; 15(7):2050.
https://doi.org/10.3390/cancers15072050
Chicago/Turabian Style
Tramsen, Lars, Konrad Bochennek, Monika Sparber-Sauer, Emilia Salzmann-Manrique, Monika Scheer, Tobias Dantonello, Arndt Borkhardt, Uta Dirksen, Anne Thorwarth, Jeanette Greiner,
and et al. 2023. "Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials" Cancers 15, no. 7: 2050.
https://doi.org/10.3390/cancers15072050
APA Style
Tramsen, L., Bochennek, K., Sparber-Sauer, M., Salzmann-Manrique, E., Scheer, M., Dantonello, T., Borkhardt, A., Dirksen, U., Thorwarth, A., Greiner, J., Ebinger, M., Weclawek-Tompol, J., Ladenstein, R., Ljungman, G., Hallmen, E., Lehrnbecher, T., Koscielniak, E., & Klingebiel, T.
(2023). Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials. Cancers, 15(7), 2050.
https://doi.org/10.3390/cancers15072050